Abstract 4358: Glucagon-like peptide 1 agonist use and the progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4358
Abstract: Background: Glucagon-like peptide 1 (GLP-1) agonists are increasingly used in diabetics due to their cardiac and renal benefits along with their actions as antihyperglycemics. They also showed inhibitory effects in ovarian, breast, prostate, and pancreatic… read more here.
Keywords: glp agonist; progression; agonist use; use progression ... See more keywords